Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KP24 Medicated Foam is a topical pharmaceutical product designed for the effective treatment and prevention of head lice infestations and their eggs. Its primary active ingredient is malathion, an organophosphate insecticide. The foam is applied to the hair and scalp, where malathion acts to kill both adult head lice and their nits (eggs) through its pediculicidal and ovicidal properties. The product is intended for external use and is recommended for children aged 6 months and up.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on KP24 Medicated Foam.